| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 2.07e-05 | 15 | 73 | 3 | GO:0008494 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.68e-05 | 18 | 73 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.44e-04 | 28 | 73 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | p53 binding | 1.82e-04 | 77 | 73 | 4 | GO:0002039 | |
| GeneOntologyMolecularFunction | structural constituent of tooth enamel | 1.96e-04 | 6 | 73 | 2 | GO:0030345 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.33e-04 | 37 | 73 | 3 | GO:0045505 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly | 3.70e-05 | 3 | 73 | 2 | GO:1903475 | |
| GeneOntologyBiologicalProcess | mitotic actomyosin contractile ring assembly actin filament organization | 3.70e-05 | 3 | 73 | 2 | GO:1903479 | |
| GeneOntologyBiologicalProcess | assembly of actomyosin apparatus involved in mitotic cytokinesis | 3.70e-05 | 3 | 73 | 2 | GO:1902407 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly actin filament organization | 7.38e-05 | 4 | 73 | 2 | GO:2000689 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 1.45e-04 | 29 | 73 | 3 | GO:0045948 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 1.78e-04 | 31 | 73 | 3 | GO:0070935 | |
| GeneOntologyBiologicalProcess | female meiosis II | 1.84e-04 | 6 | 73 | 2 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 1.84e-04 | 6 | 73 | 2 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 1.84e-04 | 6 | 73 | 2 | GO:0061983 | |
| GeneOntologyCellularComponent | inner dynein arm | 4.62e-06 | 10 | 72 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 8.53e-05 | 25 | 72 | 3 | GO:0005858 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.94e-05 | 14 | 72 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.94e-05 | 14 | 72 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.94e-05 | 14 | 72 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.94e-05 | 14 | 72 | 3 | PF08393 | |
| Domain | MT | 1.94e-05 | 14 | 72 | 3 | PF12777 | |
| Domain | AAA_8 | 1.94e-05 | 14 | 72 | 3 | PF12780 | |
| Domain | DHC_fam | 2.42e-05 | 15 | 72 | 3 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.42e-05 | 15 | 72 | 3 | IPR004273 | |
| Domain | Dynein_heavy | 2.42e-05 | 15 | 72 | 3 | PF03028 | |
| Domain | RasGAP_C | 4.39e-05 | 3 | 72 | 2 | IPR000593 | |
| Domain | RasGAP_C | 4.39e-05 | 3 | 72 | 2 | PF03836 | |
| Domain | SUZ | 8.75e-05 | 4 | 72 | 2 | IPR024771 | |
| Domain | SUZ | 8.75e-05 | 4 | 72 | 2 | PS51673 | |
| Domain | Ephrin_RBD | 4.04e-04 | 8 | 72 | 2 | IPR001799 | |
| Domain | Ephrin | 4.04e-04 | 8 | 72 | 2 | PF00812 | |
| Domain | Ephrin | 4.04e-04 | 8 | 72 | 2 | PD002533 | |
| Domain | Ephrin | 4.04e-04 | 8 | 72 | 2 | IPR031328 | |
| Domain | EPHRIN_RBD_1 | 4.04e-04 | 8 | 72 | 2 | PS01299 | |
| Domain | Ephrin_CS | 4.04e-04 | 8 | 72 | 2 | IPR019765 | |
| Domain | EPHRIN_RBD_2 | 4.04e-04 | 8 | 72 | 2 | PS51551 | |
| Domain | R3H | 5.18e-04 | 9 | 72 | 2 | SM00393 | |
| Domain | R3H | 7.88e-04 | 11 | 72 | 2 | PS51061 | |
| Domain | R3H | 7.88e-04 | 11 | 72 | 2 | PF01424 | |
| Domain | - | 7.88e-04 | 11 | 72 | 2 | 3.30.1370.50 | |
| Domain | R3H_dom | 7.88e-04 | 11 | 72 | 2 | IPR001374 | |
| Domain | RRM_1 | 1.25e-03 | 208 | 72 | 5 | PF00076 | |
| Domain | - | 1.29e-03 | 14 | 72 | 2 | 2.60.40.420 | |
| Domain | RasGAP | 1.29e-03 | 14 | 72 | 2 | SM00323 | |
| Domain | ATPase_dyneun-rel_AAA | 1.29e-03 | 14 | 72 | 2 | IPR011704 | |
| Domain | RasGAP_CS | 1.29e-03 | 14 | 72 | 2 | IPR023152 | |
| Domain | AAA_5 | 1.29e-03 | 14 | 72 | 2 | PF07728 | |
| Domain | RasGAP | 1.49e-03 | 15 | 72 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 1.49e-03 | 15 | 72 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 1.49e-03 | 15 | 72 | 2 | PS50018 | |
| Domain | RRM | 1.50e-03 | 217 | 72 | 5 | SM00360 | |
| Domain | - | 1.70e-03 | 16 | 72 | 2 | 1.10.506.10 | |
| Domain | RRM_dom | 1.83e-03 | 227 | 72 | 5 | IPR000504 | |
| Domain | Gal_mutarotase_SF_dom | 1.92e-03 | 17 | 72 | 2 | IPR011013 | |
| Domain | RRM | 1.94e-03 | 230 | 72 | 5 | PS50102 | |
| Domain | CH | 2.02e-03 | 65 | 72 | 3 | SM00033 | |
| Domain | RasGAP_dom | 2.15e-03 | 18 | 72 | 2 | IPR001936 | |
| Domain | AAA+_ATPase | 2.32e-03 | 144 | 72 | 4 | IPR003593 | |
| Domain | AAA | 2.32e-03 | 144 | 72 | 4 | SM00382 | |
| Domain | CH | 2.50e-03 | 70 | 72 | 3 | PF00307 | |
| Domain | - | 2.51e-03 | 244 | 72 | 5 | 3.30.70.330 | |
| Domain | - | 2.60e-03 | 71 | 72 | 3 | 1.10.418.10 | |
| Domain | CH | 2.82e-03 | 73 | 72 | 3 | PS50021 | |
| Domain | CH-domain | 3.04e-03 | 75 | 72 | 3 | IPR001715 | |
| Domain | Nucleotide-bd_a/b_plait | 3.19e-03 | 258 | 72 | 5 | IPR012677 | |
| Domain | Cupredoxin | 3.22e-03 | 22 | 72 | 2 | IPR008972 | |
| Domain | EGF_LAM_2 | 5.95e-03 | 30 | 72 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 5.95e-03 | 30 | 72 | 2 | PS01248 | |
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 39056782 | ||
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 1.77e-07 | 6 | 73 | 3 | 15066460 | |
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 24086306 | ||
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 1.77e-07 | 6 | 73 | 3 | 31355046 | |
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 1.77e-07 | 6 | 73 | 3 | 16001084 | |
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 11390979 | ||
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 27632217 | ||
| Pubmed | 3.09e-07 | 7 | 73 | 3 | 10857750 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 7.55e-07 | 351 | 73 | 8 | 38297188 | |
| Pubmed | 8.44e-07 | 152 | 73 | 6 | 38360978 | ||
| Pubmed | 2.50e-06 | 13 | 73 | 3 | 12511597 | ||
| Pubmed | 3.18e-06 | 14 | 73 | 3 | 9373155 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 19758243 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17204606 | ||
| Pubmed | Highly conserved epigenetic regulation of BOULE and DAZL is associated with human fertility. | 4.35e-06 | 2 | 73 | 2 | 27358391 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 27039370 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17652207 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 19342699 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 25417117 | ||
| Pubmed | Role of EFNB1 and EFNB2 in Mouse Collagen-Induced Arthritis and Human Rheumatoid Arthritis. | 4.35e-06 | 2 | 73 | 2 | 25779027 | |
| Pubmed | PERP regulates enamel formation via effects on cell-cell adhesion and gene expression. | 8.39e-06 | 19 | 73 | 3 | 21285247 | |
| Pubmed | Exosomes mediate cell contact-independent ephrin-Eph signaling during axon guidance. | 1.30e-05 | 3 | 73 | 2 | 27354374 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 28007913 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 23408838 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 30190494 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 22069310 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 25722290 | ||
| Pubmed | Human DAZL, DAZ and BOULE genes modulate primordial germ-cell and haploid gamete formation. | 1.30e-05 | 3 | 73 | 2 | 19865085 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 22493426 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 34653405 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 21976681 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 32337793 | ||
| Pubmed | Involvement of IQGAP family proteins in the regulation of mammalian cell cytokinesis. | 1.30e-05 | 3 | 73 | 2 | 25229330 | |
| Pubmed | EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells. | 1.30e-05 | 3 | 73 | 2 | 23711177 | |
| Pubmed | Expression profile of EFNB1, EFNB2, two ligands of EPHB2 in human gastric cancer. | 1.30e-05 | 3 | 73 | 2 | 12136247 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 22243238 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 7651410 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 16943546 | ||
| Pubmed | Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice. | 2.60e-05 | 4 | 73 | 2 | 19113915 | |
| Pubmed | Panel-based NGS Reveals Novel Pathogenic Mutations in Autosomal Recessive Retinitis Pigmentosa. | 2.60e-05 | 4 | 73 | 2 | 26806561 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 28970065 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 18762249 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 26549443 | ||
| Pubmed | Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. | 2.60e-05 | 4 | 73 | 2 | 20445537 | |
| Pubmed | Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands. | 2.60e-05 | 4 | 73 | 2 | 8878483 | |
| Pubmed | 3.12e-05 | 29 | 73 | 3 | 16230531 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 23579190 | ||
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 4.33e-05 | 5 | 73 | 2 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 4.33e-05 | 5 | 73 | 2 | 9288969 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 20008336 | ||
| Pubmed | Enamel formation genes are associated with high caries experience in Turkish children. | 4.33e-05 | 5 | 73 | 2 | 18781068 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 23456578 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 4.33e-05 | 5 | 73 | 2 | 8679003 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 19289155 | ||
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 4.33e-05 | 5 | 73 | 2 | 10903443 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 9143498 | ||
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 4.33e-05 | 5 | 73 | 2 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 4.33e-05 | 5 | 73 | 2 | 8845845 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 11058556 | ||
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 4.33e-05 | 5 | 73 | 2 | 19783541 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 22293198 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 17761180 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 19468308 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 4.33e-05 | 5 | 73 | 2 | 12200456 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 11514340 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 11089564 | ||
| Pubmed | Critical roles for EphB and ephrin-B bidirectional signalling in retinocollicular mapping. | 4.33e-05 | 5 | 73 | 2 | 21847105 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 23298641 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 4.33e-05 | 5 | 73 | 2 | 22223682 | |
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 4.33e-05 | 5 | 73 | 2 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 4.33e-05 | 5 | 73 | 2 | 8968756 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 4.33e-05 | 5 | 73 | 2 | 30380414 | |
| Pubmed | EphB2 and ephrin-B2 regulate the ionic homeostasis of vestibular endolymph. | 4.33e-05 | 5 | 73 | 2 | 17158005 | |
| Pubmed | Genes expressed in dental enamel development are associated with molar-incisor hypomineralization. | 4.33e-05 | 5 | 73 | 2 | 23790503 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 4.33e-05 | 5 | 73 | 2 | 26411291 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 4.33e-05 | 5 | 73 | 2 | 23223451 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 34985827 | ||
| Pubmed | EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase. | 4.33e-05 | 5 | 73 | 2 | 11983165 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 11804965 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 4.33e-05 | 5 | 73 | 2 | 14648873 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 8896558 | ||
| Pubmed | The carboxyl terminus of B class ephrins constitutes a PDZ domain binding motif. | 4.33e-05 | 5 | 73 | 2 | 9920925 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 16968134 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 9700189 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 21270429 | ||
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 8661148 | ||
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 6.48e-05 | 6 | 73 | 2 | 18452650 | |
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 11301003 | ||
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 18397270 | ||
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 6.48e-05 | 6 | 73 | 2 | 19247806 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 6.48e-05 | 6 | 73 | 2 | 23417416 | |
| Pubmed | Abnormal hippocampal axon bundling in EphB receptor mutant mice. | 6.48e-05 | 6 | 73 | 2 | 15014111 | |
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 32170089 | ||
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 16278232 | ||
| Pubmed | Exome sequencing of index patients with retinal dystrophies as a tool for molecular diagnosis. | 6.48e-05 | 6 | 73 | 2 | 23940504 | |
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 20157580 | ||
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 11703926 | ||
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 17219433 | ||
| Pubmed | Sek4 and Nuk receptors cooperate in guidance of commissural axons and in palate formation. | 6.48e-05 | 6 | 73 | 2 | 8947026 | |
| Interaction | DAZ1 interactions | 6.49e-06 | 11 | 70 | 3 | int:DAZ1 | |
| Interaction | DAZL interactions | 1.12e-05 | 145 | 70 | 6 | int:DAZL | |
| Interaction | ARID5A interactions | 1.21e-05 | 147 | 70 | 6 | int:ARID5A | |
| Interaction | KRTAP19-1 interactions | 2.13e-05 | 47 | 70 | 4 | int:KRTAP19-1 | |
| Interaction | ZNF34 interactions | 2.51e-05 | 49 | 70 | 4 | int:ZNF34 | |
| Interaction | CRX interactions | 2.84e-05 | 254 | 70 | 7 | int:CRX | |
| Interaction | PLA2G10 interactions | 4.59e-05 | 113 | 70 | 5 | int:PLA2G10 | |
| Interaction | KRTAP19-7 interactions | 5.42e-05 | 117 | 70 | 5 | int:KRTAP19-7 | |
| Interaction | TCF7 interactions | 6.76e-05 | 23 | 70 | 3 | int:TCF7 | |
| Interaction | YWHAQ interactions | TET2 MST1R ATXN2L EFNB1 USP42 ROR2 PABPC4 NCOA1 R3HDM2 BCAR1 MAPKAPK5 DNAH7 IQGAP1 | 1.09e-04 | 1118 | 70 | 13 | int:YWHAQ |
| Interaction | EPB41L4A interactions | 1.27e-04 | 140 | 70 | 5 | int:EPB41L4A | |
| Interaction | MYCBPAP interactions | 1.37e-04 | 29 | 70 | 3 | int:MYCBPAP | |
| Cytoband | 22q13.3 | 3.73e-05 | 6 | 73 | 2 | 22q13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 2.05e-03 | 157 | 73 | 3 | chr4q13 | |
| Cytoband | 4q13.3 | 2.06e-03 | 42 | 73 | 2 | 4q13.3 | |
| Cytoband | 12q12 | 2.57e-03 | 47 | 73 | 2 | 12q12 | |
| Cytoband | 7p22.1 | 2.57e-03 | 47 | 73 | 2 | 7p22.1 | |
| GeneFamily | Dyneins, axonemal | 1.24e-05 | 17 | 49 | 3 | 536 | |
| GeneFamily | Ephrins | 1.99e-04 | 8 | 49 | 2 | 546 | |
| GeneFamily | RNA binding motif containing | 2.71e-04 | 213 | 49 | 5 | 725 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 9.53e-04 | 17 | 49 | 2 | 486 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 5.26e-03 | 40 | 49 | 2 | 321 | |
| GeneFamily | Olfactory receptors, family 52 | 7.80e-03 | 49 | 49 | 2 | 165 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.48e-06 | 154 | 73 | 5 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.48e-06 | 154 | 73 | 5 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | wk_20-22-Epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.80e-05 | 197 | 73 | 5 | 468071c1911cdf8e8806a78dbceb95379e28ae91 | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 1.85e-05 | 198 | 73 | 5 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.85e-05 | 198 | 73 | 5 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 200 | 73 | 5 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.94e-05 | 200 | 73 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-05 | 200 | 73 | 5 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.20e-04 | 154 | 73 | 4 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 154 | 73 | 4 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-04 | 154 | 73 | 4 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-04 | 155 | 73 | 4 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-04 | 155 | 73 | 4 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.29e-04 | 157 | 73 | 4 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 164 | 73 | 4 | 07d9252b267cb61c6050fbfa5b440aef1349f673 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 164 | 73 | 4 | 7c016236f0cea38195c1373ebbd2c0b2b2ec81ad | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.56e-04 | 165 | 73 | 4 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.56e-04 | 165 | 73 | 4 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 167 | 73 | 4 | 78909f685ccd1321064eb0887caf9263e0e54879 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-04 | 169 | 73 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related-FDC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-04 | 169 | 73 | 4 | 49a54fb2ea9db5c45e107f304838c536908308bb | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.79e-04 | 171 | 73 | 4 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 1.87e-04 | 173 | 73 | 4 | 38f88f5bbf92a3bf5109bc4782cd071b7cb1ca34 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.95e-04 | 175 | 73 | 4 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.08e-04 | 178 | 73 | 4 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-04 | 178 | 73 | 4 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-04 | 180 | 73 | 4 | b7513b9816a9cb9f3caaddb2a9fed0be1c7f9805 | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 2.17e-04 | 180 | 73 | 4 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-04 | 180 | 73 | 4 | f96c5be4705e3d338c0393d2885ac8d5beccd6fd | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.27e-04 | 182 | 73 | 4 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-04 | 183 | 73 | 4 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.32e-04 | 183 | 73 | 4 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-04 | 183 | 73 | 4 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.36e-04 | 184 | 73 | 4 | 6e17c8151d6dc543de16d804db956c63c3fda414 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.36e-04 | 184 | 73 | 4 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | facs-Heart-RV|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-04 | 185 | 73 | 4 | 7cf2b0db059605032bfae60cf1b93c4c62608f0c | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 2.41e-04 | 185 | 73 | 4 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.41e-04 | 185 | 73 | 4 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.41e-04 | 185 | 73 | 4 | 241ea1e178fffef9e7df971de739e794332d5173 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.41e-04 | 185 | 73 | 4 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-04 | 186 | 73 | 4 | 9579180db2a0bf3f043b4d169f9a08cdc45b459a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-04 | 186 | 73 | 4 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.46e-04 | 186 | 73 | 4 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 2.51e-04 | 187 | 73 | 4 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.51e-04 | 187 | 73 | 4 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.51e-04 | 187 | 73 | 4 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.51e-04 | 187 | 73 | 4 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | Healthy_donor-pDC|World / disease group, cell group and cell class (v2) | 2.51e-04 | 187 | 73 | 4 | aa2cc54487d3c5045ac0c93560944c5a55878e27 | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.51e-04 | 187 | 73 | 4 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 2.57e-04 | 188 | 73 | 4 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.57e-04 | 188 | 73 | 4 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.57e-04 | 188 | 73 | 4 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.62e-04 | 189 | 73 | 4 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.62e-04 | 189 | 73 | 4 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.62e-04 | 189 | 73 | 4 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.62e-04 | 189 | 73 | 4 | 87189275234b5d59484c58acbb14a09903f2b578 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-04 | 189 | 73 | 4 | e82211b9dc7540e7a183be2cbcfae39fdf503949 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 2.62e-04 | 189 | 73 | 4 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 2.62e-04 | 189 | 73 | 4 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-04 | 190 | 73 | 4 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.72e-04 | 191 | 73 | 4 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.72e-04 | 191 | 73 | 4 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.72e-04 | 191 | 73 | 4 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.72e-04 | 191 | 73 | 4 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.72e-04 | 191 | 73 | 4 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.72e-04 | 191 | 73 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.72e-04 | 191 | 73 | 4 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.72e-04 | 191 | 73 | 4 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.72e-04 | 191 | 73 | 4 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.72e-04 | 191 | 73 | 4 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.72e-04 | 191 | 73 | 4 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.72e-04 | 191 | 73 | 4 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | facs-BAT-Fat-24m-Endothelial-endothelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-04 | 191 | 73 | 4 | 3550a5ed68e723182ddf85b019a6f2525a17bf52 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.72e-04 | 191 | 73 | 4 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | facs-BAT-Fat-24m-Endothelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-04 | 191 | 73 | 4 | 245ce7d1a26f9aa47acd2827b22b997886919832 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class (2021.01.30) | 2.72e-04 | 191 | 73 | 4 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | facs-BAT-Fat-24m-Endothelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-04 | 191 | 73 | 4 | 12a291918be26cb5d2b185f6a8996f4d23042cf4 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.72e-04 | 191 | 73 | 4 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | normal_Lung-Epithelial_cells-Ciliated|normal_Lung / Location, Cell class and cell subclass | 2.78e-04 | 192 | 73 | 4 | 097a13121820ab4e5cd2365600efccf5ea4ce8c3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 192 | 73 | 4 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 192 | 73 | 4 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.78e-04 | 192 | 73 | 4 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | Ciliated-cil-3|World / Class top | 2.78e-04 | 192 | 73 | 4 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 2.78e-04 | 192 | 73 | 4 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.78e-04 | 192 | 73 | 4 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 2.78e-04 | 192 | 73 | 4 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.83e-04 | 193 | 73 | 4 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-04 | 193 | 73 | 4 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 2.83e-04 | 193 | 73 | 4 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-04 | 193 | 73 | 4 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-04 | 193 | 73 | 4 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.83e-04 | 193 | 73 | 4 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-04 | 193 | 73 | 4 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-04 | 193 | 73 | 4 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-04 | 193 | 73 | 4 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.83e-04 | 193 | 73 | 4 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-04 | 193 | 73 | 4 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | control-pDC|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.83e-04 | 193 | 73 | 4 | 30a6559c9a9e8941861cb259b4836acccc427e68 | |
| Disease | Amelogenesis imperfecta type 1 | 5.84e-05 | 5 | 72 | 2 | cv:C0399367 | |
| Disease | epididymis-specific alpha-mannosidase measurement | 1.22e-04 | 7 | 72 | 2 | EFO_0801577 | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 1.22e-04 | 7 | 72 | 2 | C0399367 | |
| Disease | cognitive inhibition measurement | 2.51e-04 | 50 | 72 | 3 | EFO_0007969 | |
| Disease | testosterone measurement | TET2 ATXN2L UBE4A RBMS3 PABPC4 NCOA1 R3HDM2 MINAR1 ZMIZ1 USH2A IQGAP1 | 2.52e-04 | 1275 | 72 | 11 | EFO_0004908 |
| Disease | glucagon-like peptide-1 measurement | 2.61e-04 | 10 | 72 | 2 | EFO_0008465 | |
| Disease | cleft palate (is_implicated_in) | 3.81e-04 | 12 | 72 | 2 | DOID:674 (is_implicated_in) | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 4.28e-04 | 398 | 72 | 6 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | Colorectal Neoplasms | 5.89e-04 | 277 | 72 | 5 | C0009404 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 6.04e-04 | 15 | 72 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | focal segmental glomerulosclerosis | 6.89e-04 | 16 | 72 | 2 | EFO_0004236 | |
| Disease | Autoimmune Chronic Hepatitis | 7.80e-04 | 17 | 72 | 2 | C0241910 | |
| Disease | Amelogenesis imperfecta | 7.80e-04 | 17 | 72 | 2 | cv:C0002452 | |
| Disease | birth weight, parental genotype effect measurement | 1.27e-03 | 192 | 72 | 4 | EFO_0004344, EFO_0005939 | |
| Disease | mean arterial pressure | 1.38e-03 | 499 | 72 | 6 | EFO_0006340 | |
| Disease | Ischemic stroke, coronary artery disease | 1.50e-03 | 92 | 72 | 3 | EFO_0001645, HP_0002140 | |
| Disease | Colorectal Carcinoma | 1.62e-03 | 702 | 72 | 7 | C0009402 | |
| Disease | grip strength measurement | 1.67e-03 | 350 | 72 | 5 | EFO_0006941 | |
| Disease | digestive system infectious disorder | 1.84e-03 | 26 | 72 | 2 | MONDO_0043424 | |
| Disease | eye colour measurement | 2.01e-03 | 218 | 72 | 4 | EFO_0009764 | |
| Disease | free androgen index | 2.22e-03 | 374 | 72 | 5 | EFO_0007005 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQQYDIYERMVPPRP | 366 | Q99569 | |
| AEAPVGIYLQQMPYP | 626 | P78363 | |
| ASQYTPMLPNTYQPQ | 96 | P56945 | |
| PMLPNTYQPQPDSVY | 101 | P56945 | |
| QNKQSPLYPGMLYVP | 231 | Q9NP70 | |
| SSPVMVAQPIYQQPA | 166 | Q8N9W6 | |
| MYYVPQLRQIPPSPD | 3276 | Q8TCU4 | |
| PPTYVQNVVPQNTPM | 1581 | Q68CP9 | |
| QPGQVLHMVNELYPY | 96 | Q7Z2E3 | |
| PMPNYQVALFENEPA | 246 | Q9NYQ6 | |
| YNYQMPPQCPVGEQR | 451 | Q9NR90 | |
| SMYLQQATPPKNYQP | 581 | Q96KQ4 | |
| GFVQQPPPAQMPVYY | 626 | Q9UBL0 | |
| PAVQAPQMYPYPVSN | 721 | Q8WWM7 | |
| LMNPEAQLPQVYPFA | 411 | P46940 | |
| PQGYMQPPQQIQVSY | 506 | Q9Y2K5 | |
| GVPVYYSMIPPAQQN | 646 | Q9Y2K5 | |
| QIPPAPIMYENFYSS | 276 | Q9H939 | |
| AAPMQGTYIPQYTPV | 371 | Q6XE24 | |
| VNLFVMPYNYPVLLP | 381 | Q5JSJ4 | |
| TYNPQFEYQEPMPTA | 161 | Q68EN5 | |
| YHLMPIITPAYPQQN | 311 | Q9NRJ5 | |
| PYYTPNQLAQMRPNP | 421 | Q13310 | |
| MNSKGQYPTQPTYPV | 1 | Q15038 | |
| PNYPSFLPDQMQPQV | 346 | O43474 | |
| MTPQFTPYYVAPQVL | 181 | Q8IW41 | |
| IQDLEDMPAPQYPYI | 616 | Q6ZU64 | |
| YGHPVYIVQEMPPQS | 311 | P52799 | |
| YIVQEMPPQSPANIY | 316 | P52799 | |
| NQVYRCVYKPMQPGP | 411 | O75369 | |
| PVQNRMHYDQSQPPY | 311 | P07098 | |
| SQPPYYNVTAMNVPI | 321 | P07098 | |
| VRYQPGKYPMPNQSV | 81 | Q9NRQ2 | |
| LYVAVPPMLNPIVYG | 281 | Q96RD2 | |
| ESLRQLMPNPPLYYQ | 316 | Q6ZU69 | |
| ESLRQLMPNPPLYYQ | 46 | Q63HN1 | |
| YQRQMSEPNIPFPPQ | 211 | P50549 | |
| YPVYMVLPWEQPQQT | 146 | A1E959 | |
| VCPSNNIIYYPQMAP | 186 | Q86X67 | |
| QLPPVYPVASSMYQL | 406 | Q86VI3 | |
| NDNPPMFTQPEYRVS | 236 | Q9Y5H0 | |
| YEPKMQVPFQVLPGQ | 171 | Q9P2D7 | |
| MEQYQVPTPPEDFAV | 761 | Q9C0G6 | |
| PTVEYMNSIYNPVPW | 101 | O60678 | |
| PPAYMNIIRKNYIPN | 2761 | Q8WXX0 | |
| VQEMPPQSPANIYYK | 331 | P98172 | |
| EPTMYGEILSPNYPQ | 16 | P09871 | |
| QRMFYRPSSYQPPLQ | 241 | Q8J025 | |
| SIQMTQNYPPAIKYP | 251 | P62955 | |
| VQQYLDVVGYPFMPP | 351 | P10253 | |
| VYPNMSEPVTPANIN | 246 | Q9Y2E5 | |
| VYENTYMNITLPPPF | 21 | Q9BZJ6 | |
| QNYVPCPAPQPVQMY | 151 | Q5T749 | |
| TMPPPIESRGYYVNN | 736 | Q9NRM1 | |
| QAYPTYPNSPVQVIT | 166 | Q92904 | |
| HIQMNPYPVPEYLDN | 476 | Q9BXA9 | |
| MPYNSQYLNPVYSPV | 306 | Q9UPX6 | |
| NLYIVIPPALNPMVY | 286 | Q8NGJ2 | |
| QTPMSTPEEIYPPYN | 3766 | O75445 | |
| LYYQTNAPPSNPVAM | 1281 | P21675 | |
| PLIMEERPNLYSQPY | 981 | Q15788 | |
| FQAMATRPYYNPELP | 351 | O75603 | |
| YAPPEPIIDYNMLVI | 176 | Q8IUH8 | |
| MVPPPQLYVPVNGYQ | 811 | Q01974 | |
| GAYLPNFYPVQIPMQ | 831 | Q01974 | |
| PQSDRFQPYMQEVVP | 106 | Q9GZX6 | |
| YPAPQVSTAMVQPYN | 111 | Q9H853 | |
| YYPDLPTPEQQQDMA | 116 | P55789 | |
| MPYLDPYITQPIIQI | 696 | Q99570 | |
| AVYMQTPSQPLPTYD | 1846 | Q63HN8 | |
| RPYMSQPNGEPIVYV | 341 | Q9H9J4 | |
| VQYPARVLNMPPVIY | 321 | Q9UPX0 | |
| TMQQLPVPYQAYPHL | 161 | Q7L0R7 | |
| YQLPVYCLAPPINMI | 116 | Q8WUN7 | |
| QYNQPEVPVRSPMQF | 346 | Q9UGU0 | |
| MQPQQPYTGQIYQPT | 56 | Q969M3 | |
| VEYIQPKDPTNGQMY | 311 | Q14139 | |
| PQSQPMDLYRYPSQD | 1651 | Q6N021 | |
| LPQPEYCPDSLYQVM | 1306 | Q04912 | |
| YQYVVRNMPDPHNLP | 251 | Q6YBV0 | |
| PPTVNMGQYYKPEQF | 461 | Q9ULJ6 |